Carcinoid heart disease: A guide for screening and timing of surgical intervention

E. A. Hart, T. A. Meijs, R. C.A. Meijer, K. M. Dreijerink, M. E. Tesselaar, C. A. de Groot, G. D. Valk, S. A.J. Chamuleau

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

The cardiac manifestations of a neuroendocrine tumour are referred to as carcinoid heart disease (CaHD) and are associated with a poor prognosis. Surgical intervention is the only proven therapeutic option and may prolong survival and quality of life. No consensus has been reached internationally with regard to screening for CaHD and the optimal timing for surgery. Although limited evidence is available on this matter, a trend towards early surgery and subsequent reduced mortality has been observed. In this review we provide an overview of the current understanding and propose a protocol to guide cardiologists in the screening for CaHD and the timing of referral to a specialised surgical centre.

Original languageEnglish
Pages (from-to)471-478
Number of pages8
JournalNetherlands Heart Journal
Volume25
Issue number9
DOIs
Publication statusPublished - 2017
Externally publishedYes

Cite this

Hart, E. A., Meijs, T. A., Meijer, R. C. A., Dreijerink, K. M., Tesselaar, M. E., de Groot, C. A., ... Chamuleau, S. A. J. (2017). Carcinoid heart disease: A guide for screening and timing of surgical intervention. Netherlands Heart Journal, 25(9), 471-478. https://doi.org/10.1007/s12471-017-1011-2
Hart, E. A. ; Meijs, T. A. ; Meijer, R. C.A. ; Dreijerink, K. M. ; Tesselaar, M. E. ; de Groot, C. A. ; Valk, G. D. ; Chamuleau, S. A.J. / Carcinoid heart disease : A guide for screening and timing of surgical intervention. In: Netherlands Heart Journal. 2017 ; Vol. 25, No. 9. pp. 471-478.
@article{1b1850158ba1445fa887a9a7c39ad4f1,
title = "Carcinoid heart disease: A guide for screening and timing of surgical intervention",
abstract = "The cardiac manifestations of a neuroendocrine tumour are referred to as carcinoid heart disease (CaHD) and are associated with a poor prognosis. Surgical intervention is the only proven therapeutic option and may prolong survival and quality of life. No consensus has been reached internationally with regard to screening for CaHD and the optimal timing for surgery. Although limited evidence is available on this matter, a trend towards early surgery and subsequent reduced mortality has been observed. In this review we provide an overview of the current understanding and propose a protocol to guide cardiologists in the screening for CaHD and the timing of referral to a specialised surgical centre.",
keywords = "Carcinoid heart disease, Hedinger syndrome, Screening, Surgery, Valvular disease",
author = "Hart, {E. A.} and Meijs, {T. A.} and Meijer, {R. C.A.} and Dreijerink, {K. M.} and Tesselaar, {M. E.} and {de Groot}, {C. A.} and Valk, {G. D.} and Chamuleau, {S. A.J.}",
year = "2017",
doi = "10.1007/s12471-017-1011-2",
language = "English",
volume = "25",
pages = "471--478",
journal = "Netherlands Heart Journal",
issn = "1568-5888",
publisher = "Bohn Stafleu van Loghum",
number = "9",

}

Hart, EA, Meijs, TA, Meijer, RCA, Dreijerink, KM, Tesselaar, ME, de Groot, CA, Valk, GD & Chamuleau, SAJ 2017, 'Carcinoid heart disease: A guide for screening and timing of surgical intervention' Netherlands Heart Journal, vol. 25, no. 9, pp. 471-478. https://doi.org/10.1007/s12471-017-1011-2

Carcinoid heart disease : A guide for screening and timing of surgical intervention. / Hart, E. A.; Meijs, T. A.; Meijer, R. C.A.; Dreijerink, K. M.; Tesselaar, M. E.; de Groot, C. A.; Valk, G. D.; Chamuleau, S. A.J.

In: Netherlands Heart Journal, Vol. 25, No. 9, 2017, p. 471-478.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Carcinoid heart disease

T2 - A guide for screening and timing of surgical intervention

AU - Hart, E. A.

AU - Meijs, T. A.

AU - Meijer, R. C.A.

AU - Dreijerink, K. M.

AU - Tesselaar, M. E.

AU - de Groot, C. A.

AU - Valk, G. D.

AU - Chamuleau, S. A.J.

PY - 2017

Y1 - 2017

N2 - The cardiac manifestations of a neuroendocrine tumour are referred to as carcinoid heart disease (CaHD) and are associated with a poor prognosis. Surgical intervention is the only proven therapeutic option and may prolong survival and quality of life. No consensus has been reached internationally with regard to screening for CaHD and the optimal timing for surgery. Although limited evidence is available on this matter, a trend towards early surgery and subsequent reduced mortality has been observed. In this review we provide an overview of the current understanding and propose a protocol to guide cardiologists in the screening for CaHD and the timing of referral to a specialised surgical centre.

AB - The cardiac manifestations of a neuroendocrine tumour are referred to as carcinoid heart disease (CaHD) and are associated with a poor prognosis. Surgical intervention is the only proven therapeutic option and may prolong survival and quality of life. No consensus has been reached internationally with regard to screening for CaHD and the optimal timing for surgery. Although limited evidence is available on this matter, a trend towards early surgery and subsequent reduced mortality has been observed. In this review we provide an overview of the current understanding and propose a protocol to guide cardiologists in the screening for CaHD and the timing of referral to a specialised surgical centre.

KW - Carcinoid heart disease

KW - Hedinger syndrome

KW - Screening

KW - Surgery

KW - Valvular disease

UR - http://www.scopus.com/inward/record.url?scp=85029226279&partnerID=8YFLogxK

U2 - 10.1007/s12471-017-1011-2

DO - 10.1007/s12471-017-1011-2

M3 - Review article

VL - 25

SP - 471

EP - 478

JO - Netherlands Heart Journal

JF - Netherlands Heart Journal

SN - 1568-5888

IS - 9

ER -